{"created":"2023-07-27T06:54:15.114066+00:00","id":49453,"links":{},"metadata":{"_buckets":{"deposit":"470c3244-dbc9-4ae0-850c-7bc56b74cdec"},"_deposit":{"created_by":18,"id":"49453","owners":[18],"pid":{"revision_id":0,"type":"depid","value":"49453"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00049453","sets":["2812:2813:2815"]},"author_link":["78766","78765"],"item_9_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2019-06-17","bibliographicIssueDateType":"Issued"},"bibliographicPageStart":"6p.","bibliographicVolumeNumber":"2016-04-01 - 2019-03-31","bibliographic_titles":[{"bibliographic_title":"平成30(2018)年度 科学研究費補助金 若手研究(B) 研究成果報告書"},{"bibliographic_title":"2018 Fiscal Year Final Research Report","bibliographic_titleLang":"en"}]}]},"item_9_creator_33":{"attribute_name":"著者別表示","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{}],"nameIdentifiers":[{},{}]}]},"item_9_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"甲状腺分化癌患者に対する分子標的薬の適応を決める際に、I-131内用療法前のrhTSH診断シンチグラフィが有用かどうか検討した。残存甲状腺組織を有しかつ転移病巣を有する分化型甲状腺癌患者において、I-131内用療法前のrhTSH診断シンチグラフィは、分子標的薬の導入を超早期に判断する材料の一助になり得る可能性があることを示した。rhTSH診断シンチグラフィを施行することによって、I-131内用療法の効果が期待できない、いわゆるI-131治療抵抗性の患者を超早期に検出することが可能であり、早い段階で分子標的薬の導入を決定することが可能であることを示した。","subitem_description_type":"Abstract"},{"subitem_description":"We investigated whether radioiodine-131 (I-131) diagnostic scintigraphy under ricombinant human thyroid-stimulating hormone (rhTSH) was useful or not for the decision about the indication for novel molecular-targeted drug in different thyroid cancer. We proved that I-131 diagnostic scintigraphy under rhTSH before I-131 therapy could be useful for the decision about the indication for novel molecular-targeted drug in patients with differentiated thyroid cancer who have thyroid remnant tissue and metastases. ","subitem_description_type":"Abstract"}]},"item_9_description_22":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"研究課題/領域番号:16K19810, 研究期間(年度):2016-04-01 - 2019-03-31","subitem_description_type":"Other"},{"subitem_description":"出典：研究課題「甲状腺分化癌における新規分子標的薬の超早期適応決定」課題番号16K19810\n（KAKEN：科学研究費助成事業データベース（国立情報学研究所）） \n（https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-16K19810/16K19810seika/）を加工して作成","subitem_description_type":"Other"}]},"item_9_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.24517/00055765","subitem_identifier_reg_type":"JaLC"}]},"item_9_publisher_17":{"attribute_name":"公開者","attribute_value_mlt":[{"subitem_publisher":"金沢大学附属病院核医学診療科"}]},"item_9_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/search/?qm=10547152"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/search/?qm=10547152","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K19810/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K19810/","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-16K19810/16K19810seika/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-16K19810/16K19810seika/","subitem_relation_type_select":"URI"}}]},"item_9_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-05-14"}],"displaytype":"detail","filename":"HO-PR-KAYANO-D-kaken 2019-6p.pdf","filesize":[{"value":"94.2 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"HO-PR-KAYANO-D-kaken 2019-6p.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/49453/files/HO-PR-KAYANO-D-kaken 2019-6p.pdf"},"version_id":"ed399700-cfc0-4a96-aebe-7b16f0e0dc0c"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"甲状腺分化癌における新規分子標的薬の超早期適応決定","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"甲状腺分化癌における新規分子標的薬の超早期適応決定"},{"subitem_title":"Early decision about the indication for novel molecular-targeted drug in differentiated thyroid cancer","subitem_title_language":"en"}]},"item_type_id":"9","owner":"18","path":["2815"],"pubdate":{"attribute_name":"公開日","attribute_value":"2020-05-14"},"publish_date":"2020-05-14","publish_status":"0","recid":"49453","relation_version_is_last":true,"title":["甲状腺分化癌における新規分子標的薬の超早期適応決定"],"weko_creator_id":"18","weko_shared_id":-1},"updated":"2023-07-27T13:32:28.303164+00:00"}